These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

889 related articles for article (PubMed ID: 18520599)

  • 21. Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients.
    Shipkova M; Armstrong VW; Weber L; Niedmann PD; Wieland E; Haley J; Tönshoff B; Oellerich M;
    Ther Drug Monit; 2002 Jun; 24(3):390-9. PubMed ID: 12021631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of MPA and MPAG removal by continuous venovenous hemodiafiltration and continuous venovenous hemofiltration.
    Cussonneau X; Bolon-Larger M; Prunet-Spano C; Bastien O; Boulieu R
    Ther Drug Monit; 2008 Feb; 30(1):100-2. PubMed ID: 18223470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism.
    van Agteren M; Armstrong VW; van Schaik RH; de Fijter H; Hartmann A; Zeier M; Budde K; Kuypers D; Pisarski P; Le Meur Y; van der Werf M; Mamelok RD; Oellerich M; van Gelder T
    Ther Drug Monit; 2008 Aug; 30(4):439-44. PubMed ID: 18641546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients.
    de Winter BC; van Gelder T; Sombogaard F; Shaw LM; van Hest RM; Mathot RA
    J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):541-64. PubMed ID: 19904584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of enteric-coated mycophenolate sodium in stable pediatric renal transplant recipients.
    Ettenger R; Bartosh S; Choi L; Zhu W; Niederberger W; Campestrini J; Bastien MC; Schmouder R
    Pediatr Transplant; 2005 Dec; 9(6):780-7. PubMed ID: 16269051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.
    Figurski MJ; Nawrocki A; Pescovitz MD; Bouw R; Shaw LM
    Ther Drug Monit; 2008 Aug; 30(4):445-55. PubMed ID: 18641543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limited sampling strategies for predicting area under the concentration-time curve of mycophenolic acid in islet transplant recipients.
    Al-Khatib M; Shapiro RJ; Partovi N; Ting LS; Levine M; Ensom MH
    Ann Pharmacother; 2010 Jan; 44(1):19-27. PubMed ID: 19996322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of mycophenolic acid and glucuronide metabolites in human plasma and the impact of deproteinization methodology.
    de Loor H; Naesens M; Verbeke K; Vanrenterghem Y; Kuypers DR
    Clin Chim Acta; 2008 Mar; 389(1-2):87-92. PubMed ID: 18157945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycophenolic acid pharmacokinetics in lung transplant recipients with cystic fibrosis.
    Stuckey L; Clark Ojo T; Park JM; Annesley T; Bartos C; Cibrik DM
    Ther Drug Monit; 2014 Apr; 36(2):148-51. PubMed ID: 24232127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
    Blanchet B; Taieb F; Conti F; Abbas H; Seydi I; Harcouet L; Dauphin A; Calmus Y; Tod M
    Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous determination of mycophenolic acid and its glucuronides in human plasma using isocratic ion pair high-performance liquid chromatography.
    Mino Y; Naito T; Matsushita T; Kagawa Y; Kawakami J
    J Pharm Biomed Anal; 2008 Feb; 46(3):603-8. PubMed ID: 18164890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic modeling of enterohepatic circulation of mycophenolic acid in renal transplant recipients.
    Colom H; Lloberas N; Andreu F; Caldés A; Torras J; Oppenheimer F; Sanchez-Plumed J; Gentil MA; Kuypers DR; Brunet M; Ekberg H; Grinyó JM
    Kidney Int; 2014 Jun; 85(6):1434-43. PubMed ID: 24402086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients.
    Barten MJ; Rahmel A; Garbade J; Bold A; Bittner HB; Dhein S; Mohr FW; Gummert JF
    Transplant Proc; 2005 Dec; 37(10):4532-4. PubMed ID: 16387162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients.
    Kuypers DR; Naesens M; Vermeire S; Vanrenterghem Y
    Clin Pharmacol Ther; 2005 Oct; 78(4):351-61. PubMed ID: 16198654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPLC determination of mycophenolic acid and mycophenolic acid glucuronide in human plasma with hybrid material.
    Bolon M; Jeanpierre L; El Barkil M; Chelbi K; Sauviat M; Boulieu R
    J Pharm Biomed Anal; 2004 Nov; 36(3):649-51. PubMed ID: 15522544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitive high-performance liquid chromatography-tandem mass spectrometry method for quantitative analysis of mycophenolic acid and its glucuronide metabolites in human plasma and urine.
    Benoit-Biancamano MO; Caron P; Lévesque E; Delage R; Couture F; Guillemette C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):159-67. PubMed ID: 17827076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacokinetics of mycophenolate mofetil.
    Bullingham RE; Nicholls AJ; Kamm BR
    Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil.
    Morissette P; Albert C; Busque S; St-Louis G; Vinet B
    Ther Drug Monit; 2001 Oct; 23(5):520-5. PubMed ID: 11591897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycophenolic Acid Metabolites Acyl-Glucuronide and Glucoside Affect the Occurrence of Infectious Complications and Bone Marrow Dysfunction in Liver Transplant Recipients.
    Zegarska J; Hryniewiecka E; Żochowska D; Tszyrsznic W; Jaźwiec R; Borowiec A; Pawłowska E; Dadlez M; Pączek L
    Ann Transplant; 2015 Aug; 20():483-92. PubMed ID: 26313036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycophenolic acid clinical pharmacokinetics influenced by a cyclosporine C2 based immunosuppressive regimen in renal allograft recipients.
    Mandla R; Midtvedt K; Line PD; Hartmann A; Bergan S
    Transpl Int; 2006 Jan; 19(1):44-53. PubMed ID: 16359376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.